Kidney regeneration approaches for translation

Area of Science:

• Nephrology
• Regenerative Medicine
• Biotechnology

Background:

• Rising incidence of chronic kidney diseases (CKD) progressing to end-stage renal disease (ESRD) presents a significant global health challenge.
• Kidney transplantation is the only definitive treatment for ESRD, but a severe shortage of donor organs leads to high mortality rates among patients awaiting transplants.
• Current treatments like dialysis can prolong survival but do not restore renal function.

Purpose of the Study:

• To review current strategies and progress in tissue engineering and regenerative medicine for developing alternative therapeutic options for CKD.
• To explore both cell-based and cell-free approaches aimed at addressing the challenges posed by CKD.
• To highlight the potential of these innovative therapies in providing solutions for patients with kidney failure.

Main Methods:

• Review of recent scientific literature and clinical studies on tissue engineering and regenerative medicine applied to kidney disease.
• Analysis of cell-based strategies, including stem cell therapies and bioengineered kidney constructs.
• Examination of cell-free approaches, such as therapeutic exosomes and growth factor delivery systems.

Main Results:

• Tissue engineering and regenerative medicine are emerging as viable therapeutic avenues for kidney disease.
• Both cell-based and cell-free strategies show potential in preclinical and early clinical studies.
• Significant progress has been made in developing bio-artificial kidneys and regenerative therapies.

Conclusions:

• Tissue engineering and regenerative medicine hold significant promise for overcoming the donor organ shortage in kidney transplantation.
• Cell-based and cell-free approaches represent innovative solutions for treating chronic kidney diseases and end-stage renal disease.
• Further research and clinical translation are crucial to realize the full therapeutic potential of these regenerative strategies.